FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $705,771 | -54.4% | 332,911 | +22.7% | 0.00% | -66.7% |
| Q1 2023 | $1,546,974 | +158.3% | 271,399 | +1658.0% | 0.00% | +200.0% |
| Q1 2022 | $599,000 | -61.8% | 15,438 | -42.5% | 0.00% | -66.7% |
| Q4 2021 | $1,570,000 | -26.7% | 26,831 | -25.7% | 0.00% | -25.0% |
| Q3 2021 | $2,142,000 | -35.3% | 36,132 | -5.2% | 0.00% | -33.3% |
| Q2 2021 | $3,309,000 | +18.6% | 38,124 | +12.6% | 0.01% | +20.0% |
| Q1 2021 | $2,791,000 | -13.1% | 33,847 | -4.2% | 0.01% | -16.7% |
| Q4 2020 | $3,212,000 | +98.4% | 35,322 | -12.8% | 0.01% | +100.0% |
| Q3 2020 | $1,619,000 | -4.7% | 40,506 | -18.1% | 0.00% | 0.0% |
| Q2 2020 | $1,698,000 | +45.6% | 49,485 | -5.7% | 0.00% | +50.0% |
| Q1 2020 | $1,166,000 | +211.8% | 52,479 | +175.0% | 0.00% | – |
| Q4 2019 | $374,000 | -18.5% | 19,086 | -35.5% | 0.00% | -100.0% |
| Q3 2019 | $459,000 | -24.6% | 29,579 | -1.3% | 0.00% | 0.0% |
| Q2 2019 | $609,000 | +2.7% | 29,982 | -11.2% | 0.00% | 0.0% |
| Q1 2019 | $593,000 | +19.1% | 33,772 | -13.0% | 0.00% | 0.0% |
| Q4 2018 | $498,000 | -35.2% | 38,814 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $769,000 | +43.7% | 47,207 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $535,000 | +70.9% | 47,207 | +47.4% | 0.00% | – |
| Q1 2018 | $313,000 | – | 32,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |